News And Announcements
Greencoat Renewables issuing up to 400m shares to fund pipeline
Renewable infrastructure investment company Greencoat Renewables announced a 12-month share issue programme of up to 400 million new shares on Monday, to fund its growing pipeline of opportunities in continental Europe and Ireland.
Future profit seen at top end of forecast range, CFO to leave
Media group Future said on Monday that full-year operating profit is set to be at the top end of expectations thanks to continued momentum in digital advertising, as it announced the departure of its chief financial officer.
James Halstead board proposes another record dividend
Commercial, contract and consumer flooring company James Halstead reported an 11. 6% improvement in its full-year revenue on Monday, to £266. 4m, as its profit before tax rose 16. 9% to £51. 3m.
FirstGroup buys out Hinkley C worker transport joint venture
FirstGroup announced on Monday that its wholly-owned subsidiary First South West has acquired the remaining 50% shareholding in its Somerset Passenger Solutions (SPS) joint venture.
Flutter names Amy Howe as CEO of FanDuel
Bookmaker Flutter has appointed Amy Howe as permanent chief executive of its American gambling subsidiary FanDuel.
Compass Group taps Palmer Brown for CFO
Foodservice company Compass Group revealed on Monday that chief financial officer Karen Witts will step down from the role at the end of October.
Ryanair reports rise in September traffic, load factor
Budget airline Ryanair reported a rise in September traffic and its load factor on Monday.
Discoverie sells South African business for up to £2.25m
Discoverie has sold its South African distribution business, Vertec, to its management team and key employees for an upfront cash consideration of £1. 25m.
Plus500 sees FY revenues, earnings ahead of views
Online trading platform Plus500 said on Monday that it now expects 2021 revenue and core earnings to be ahead of analyst forecasts after delivering "further positive momentum" in the third quarter.
AstraZeneca breast cancer drug wins US breakthrough therapy designation
AstraZeneca said its breast cancer drug Enhertu had been granted breakthrough therapy designation (BTD) in the US.